SUPERIOR VENA-CAVA SYNDROME AFTER IMPLANTATION OF A TRANSVENOUS CARDIOVERTER-DEFIBRILLATOR

Citation
E. Dhondt et al., SUPERIOR VENA-CAVA SYNDROME AFTER IMPLANTATION OF A TRANSVENOUS CARDIOVERTER-DEFIBRILLATOR, European heart journal, 16(5), 1995, pp. 716-718
Citations number
10
Categorie Soggetti
Cardiac & Cardiovascular System
Journal title
ISSN journal
0195668X
Volume
16
Issue
5
Year of publication
1995
Pages
716 - 718
Database
ISI
SICI code
0195-668X(1995)16:5<716:SVSAIO>2.0.ZU;2-D
Abstract
Superior vena cava syndrome is a rare, but nevertheless well known com plication of permanent pacemaker implantation. Nowadays cardioverter d efibrillators are also routinely implanted transvenously. A superior v ena cava syndrome occurred in a 48-year-old female 2 years after impla ntation of cardioverter defibrillator. The clinical problem, in the pr esence of a predisposing thrombophilic condition (circulating lupus an ticoagulant), resolved only partially after treatment with thrombolyti cs and oral anticoagulation. This syndrome should be recognized as a p ossible important complication of defibrillator therapy and requires l ifelong anticoagulation.